Perrigo (PRGO) Free Cash Flow Growth (1y) (2014 - 2026)
Perrigo (PRGO) Free Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 44.93% |
| 10 | Perrigo | 1.43 Bn | 1.08 Bn | 325.50 Mn | -41.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -41.56% |
| Dec 31, 2025 | -45.94% |
| Sep 27, 2025 | 97.35% |
| Jun 28, 2025 | 400.00% |
| Mar 29, 2025 | -239.62% |
| Dec 31, 2024 | 51.04% |
| Sep 28, 2024 | -83.71% |
| Jun 29, 2024 | -157.45% |
| Mar 30, 2024 | -597.37% |
| Dec 31, 2023 | 82.36% |
| Sep 30, 2023 | -5.02% |
| Jul 1, 2023 | 172.63% |
| Apr 1, 2023 | -106.46% |
| Dec 31, 2022 | 153.40% |
| Oct 1, 2022 | -71.43% |
| Jul 2, 2022 | 56.98% |
| Apr 2, 2022 | 230.09% |
| Dec 31, 2021 | -621.62% |
| Oct 2, 2021 | 452.75% |
| Jul 3, 2021 | -136.07% |